![quarterly-report-stock-investing-market-](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_t0JOeINTXAuAeuIwgq-OuVuYqEUfeg2cMf3miDbP0VhP2_lGBmGg7Hg_CLDDJTpPQ4cEYtvgpulw=s0-d "An investor in a suit clicking on the "quarterly report" tab on his digital screen.")
What happened Shares of Valeant Pharmaceuticals NYSE VRX an embattled drugmaker known for growing by acquisition and raising prices on mature therapies exploded 30 higher in May according to data from S amp P Global Market Intelligence The reason for the surge
June 08, 2017 at 03:50AM
from
No comments:
Post a Comment